Maciej Kuźmierkiewicz, general manager of IQVIA Poland and the Baltics, discusses the implications of global changes on the Polish affiliate (which now employs 1000 staff) and the challenges of promoting an abundance of services to the marketplace. Additionally, he highlights the potential of healthcare services in Poland to deliver clinical trials and how this will be further enabled by IQVIA – the new brand of the merged company of IMS Health and Quintiles.
The company has experienced many changes at the global level. What impact has this had on the operations of the Polish affiliate?
"Our “next generation” service for clinical trials is a unique value proposition of IQVIA and is an area that many of our competitors are now attempting to follow and replicate."
